BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16633028)

  • 1. Prevention and treatment of corneal graft rejection: current practice patterns (2004).
    Randleman JB; Stulting RD
    Cornea; 2006 Apr; 25(3):286-90. PubMed ID: 16633028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011).
    Kharod-Dholakia B; Randleman JB; Bromley JG; Stulting RD
    Cornea; 2015 Jun; 34(6):609-14. PubMed ID: 25811719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantation.
    Holland EJ; Djalilian AR; Sanderson JP
    Cornea; 2009 Dec; 28(10):1139-43. PubMed ID: 19770719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal graft rejection.
    Panda A; Vanathi M; Kumar A; Dash Y; Priya S
    Surv Ophthalmol; 2007; 52(4):375-96. PubMed ID: 17574064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
    Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
    Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of steroid usage patterns during and after low-risk penetrating keratoplasty.
    Price FW; Price DA; Ngakeng V; Price MO
    Cornea; 2009 Sep; 28(8):865-70. PubMed ID: 19654531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for the first episode of corneal graft rejection in keratoconus.
    Epstein AJ; de Castro TN; Laibson PR; Cohen EJ; Rapuano CJ
    Cornea; 2006 Oct; 25(9):1005-11. PubMed ID: 17133044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opinions on risk factors and management of corneal graft rejection in the United kingdom.
    Koay PY; Lee WH; Figueiredo FC
    Cornea; 2005 Apr; 24(3):292-6. PubMed ID: 15778601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loteprednol Etabonate 0.5% Gel Vs. Prednisolone Acetate 1% Solution After Descemet Membrane Endothelial Keratoplasty: Prospective Randomized Trial.
    Price MO; Feng MT; Scanameo A; Price FW
    Cornea; 2015 Aug; 34(8):853-8. PubMed ID: 26020827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential diagnosis and therapy of graft rejection after keratoplasty].
    Pleyer U; Bertelmann E
    Klin Monbl Augenheilkd; 2005 Nov; 222(11):863-9. PubMed ID: 16308817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current practice of immune prophylaxis and therapy in perforating keratoplasty. A survey of members of the Cornea Section of the German Ophthalmological Society].
    Bertelmann E; Reinhard T; Pleyer U
    Ophthalmologe; 2003 Dec; 100(12):1031-5. PubMed ID: 14704815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment.
    Dua HS; Azuara-Blanco A
    Indian J Ophthalmol; 1999 Mar; 47(1):3-9. PubMed ID: 16130277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty.
    Nguyen NX; Seitz B; Martus P; Langenbucher A; Cursiefen C
    Am J Ophthalmol; 2007 Aug; 144(2):318-9. PubMed ID: 17659972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current practices in the prevention and treatment of corneal graft rejection.
    Rinne JR; Stulting RD
    Cornea; 1992 Jul; 11(4):326-8. PubMed ID: 1424653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corneal transplant rejection rate and severity after endothelial keratoplasty.
    Allan BD; Terry MA; Price FW; Price MO; Griffin NB; Claesson M
    Cornea; 2007 Oct; 26(9):1039-42. PubMed ID: 17893530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal transplant survival after onset of severe endothelial rejection.
    Wagoner MD; Ba-Abbad R; Sutphin JE; Zimmerman MB
    Ophthalmology; 2007 Sep; 114(9):1630-6. PubMed ID: 17367863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model of corneal transplantation in the miniature pig: efficacy of immunosuppressive treatment.
    Tavandzi U; Procházka R; Usvald D; Hlucílová J; Vitásková M; Motlík J; Vítová A; Filipec M; Forrester JV; Holán V
    Transplantation; 2007 May; 83(10):1401-3. PubMed ID: 17519795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty.
    Dhaliwal JS; Mason BF; Kaufman SC
    Cornea; 2008 May; 27(4):488-93. PubMed ID: 18434855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression in corneal transplantation.
    Hill JC
    Eye (Lond); 1995; 9 ( Pt 2)():247-53. PubMed ID: 7556726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.